ENGN
enGene Therapeutics Inc.
-0.02 (-0.86%)1.89USD175K成交股數127M市值0.8本益比(近四季)–股價營收比–營收年增(近四季)2026-09-08下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 10 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 20.1M | 22.2M | 22.3M | 31.7M | 22.6M | 20.2M | 20.0M | 11.5M | 9.9M | 5.6M | 5.7M | 3.9M |
| 銷售管理費用 | 13.9M | 9.8M | 8.9M | 7.8M | 7.4M | 6.9M | 6.6M | 5.2M | 7.5M | 5.1M | 4.8M | 2.3M |
| 營業利益 | −34.0M+14% | −32.0M+18% | −31.2M+17% | −39.5M+136% | −29.9M+73% | −27.1M+152% | −26.6M+155% | −16.8M+168% | −17.3M | −10.8M | −10.4M | −6.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −32.5M+12% | −30.2M+17% | −29.8M+21% | −37.9M+168% | −29.0M+93% | −25.8M+141% | −24.6M-70% | −14.1M+200% | −15.0M | −10.7M | −82.5M | −4.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.47-18% | -0.43-16% | 0.44-8% | 2.89+803% | -0.57-250% | -0.51-211% | 0.48-100% | 0.32-96% | 0.38 | 0.46 | 120.08 | 8.55 |
| 稀釋股數 | 69.7M | 69.7M | 67.3M | 51.1M | 51.1M | 51.0M | 51.0M | 44.2M | 39.4M | 23.2M | 693K | 701K |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 41.0M | 29.8M | 36.6M | 50.2M | 32.6M | 57.5M | 62.3M | 258M | 265M | 85.6M | 81.5M | – |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 288M | 308M | 337M | 221M | 246M | 267M | 286M | 267M | 274M | 93.4M | 87.0M | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 58.0M | 52.4M | 55.6M | 53.8M | 44.9M | 39.4M | 36.0M | 36.6M | 30.6M | 31.0M | 14.5M | – |
| 股東權益 | 230M | 255M | 282M | 168M | 201M | 227M | 250M | 230M | 243M | 62.4M | 72.5M | −93.9M |
| 負債比 | 20.1% | 17.0% | 16.5% | 24.3% | 18.3% | 14.8% | 12.6% | 13.7% | 11.2% | 33.2% | 16.6% | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −28.9M+12% | – | – | – | −25.7M | – | – | −7.4M | – | – |
| 資本支出 | – | – | 153K | – | – | – | 299K | – | – | 506K | – | – |
| 自由現金流 | – | – | −29.1M+12% | – | – | – | −26.0M | – | – | −7.9M | – | – |
| 折舊攤銷 | 100K | 200K | 189K | 198K | 100K | 100K | 102K | 100K | 100K | 80K | 74K | 43K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −117M | –% | 2.29 | −101M |
| FY2024 | – | – | −55.1M | –% | 1.46 | −49.2M |
| FY2023 | – | – | −99.9M | –% | 151.22 | −25.1M |
| FY2022 | – | – | −24.5M | –% | 44.30 | −17.7M |